Bursera graveolens is a wild tree of commercial importance native to the Neotropics, which has been widely used in folk medicine. In the present study, the chemical composition and anti-proliferative properties of the essential oil from B. graveolens were assayed. The chemical composition of the essential oil, determined by GC-MS, was complex and dominated by limonene (26.5%). Bursera oil inhibited the growth of MCF-7 breast tumor cells as well as amastigotes of L. amazonensis, with IC 50 values of 48.9 ± 4.3 and 36.7 ± 4.7 g/mL, respectively. In addition, the cytotoxicity of the oil was 103.9 ± 7.2 g/mL against peritoneal macrophages from BALB/c mice. These results demonstrate that the essential oil from B. graveolens is a promissory antiproliferative product.
Burseraceae is a moderate-sized family composed by 17-18 genera and about 540 species of flowering plants. The actual numbers differ according to the time period in which a given source is written describing this family. Burseraceae is also known as the torchwood family, the frankincense and myrrh family, or simply the incense tree family. The family includes both trees and shrubs, and is native to tropical regions of Africa, Asia and the Americas [1].
Bursera graveolens
Triana & Planch is one species of the family with commercial importance. The plant is a wild tree, native to tropical America (from Mexico south into Peru) and it is widely used in folk medicine for stomach ache, as sudorific, and as liniment for rheumatism [1a] .
In general, Burseraceae trees or shrubs are chemically characterized by resins, which contain triterpenoids and ethereal oils. Therefore, a complex mixture of compounds can be present in the plant, which impart characteristic aromas and medicinal properties. Herein was studied the activity of the oil of B. graveolens against a cancer cell line (MCF-7) and against a protozoal parasite (Leishmania amazonensis) as models to evaluate the anti-proliferative properties of the Bursera oil.
The composition of the essential oil was determined by GC-MS and the major components were identified (Table 1 ). The Bursera oil was dominated by limonene (26.5%), β-elemene (14.1%), (E)-βocimene (13.0%), and menthofuran (5.1%). The EO inhibited the growth of both breast tumor cells and amastigotes of L. amazonensis ( Table 2 ). In addition, murine macrophages were also treated to determine safety and selectivity. The CC 50 showed higher values compared with IC 50 of the tumor cell line and Leishmania parasite.
Cancer is one of the most dreaded diseases worldwide and the incidence is on the rise in both developing and developed countries. Approved therapies include chemotherapy, radiotherapy, and surgery. In spite of advances in therapeutic strategies, cancer still remains a major cause of death. Research is going forward in order to obtain better drugs, more effective and with fewer side effects [2] .
On the other hand, leishmaniasis, caused by parasites of Leishmania genus, currently affects more than 12 million people in 88 countries [3] . The control of leishmaniasis remains a serious problem. As a zoonotic infection, transmission is difficult to interrupt, although some attempts to reduce vector and mammalian reservoir populations have been successful. There are currently no vaccines for leishmaniasis prevention. The drugs available for leishmaniasis therapy are toxic, expensive, and frequently ineffective [4] . The problems previously mentioned, emphasize the importance of the development of new drugs against leishmaniasis [5] .
Currently, natural products have played a significant role in drug discovery and development especially for agents against cancer and infectious diseases. Natural compounds possess highly diverse and complex molecular structures compared to small-molecule synthetic drugs and often provide highly specific biological activities derived from the rigidity and high number of chiral carbons [6] . In particular, essential oils from plants have showed anti-tumor [7] and anti-leishmanial [8] activity. In this sense, the anti-proliferative potential of essential oil from B. graveolens has been explored in our laboratories as a potential chemotherapeutic agent. Essential oils are composed by a complex mixture of compounds. A previous investigation of B. graveolens has revealed the essential oil from the stems to contain limonene, α-terpineol, menthofuran, carvone, germacrene, γ-muurolene, carveol and pulegone as major constituents [9] , whereas another stem sample was composed largely of viridiflorol (70.8%) with a smaller amount of limonene (4.8%) [10] . A previous examination of the leaf oil showed it to be composed largely of limonene (30.7%), (E)-β-ocimene (20.8%), and β-elemene (11.3%) [11] . Thus, the composition of the oil evaluated in this current investigation is similar to this previous report, with limonene as the main compound. B. simaruba leaf oil NPC Natural Product Communications 2012 Vol. 7 No. 11 1531 -1534 has also been shown to be rich in limonene [12] . Limonene, a natural cyclic monoterpene, is one of the most common constituent of several citrus oils, which have been used especially in aromatherapy [13] . Germacrene D, but not limonene, has been found to be an abundant component in the leaf oils of many Bursera species [14] , but is a relatively minor component of B. graveolens in this current study.
B. graveolens oil showed in-vitro cytotoxic activity against the MCF-7 cancer cell line as well as Leishmania, with IC 50 values less than 50 µg/mL; one-third as high as the IC 50 for normal macrophages, which demonstrated the selectivity degree of the oil. These properties of B. graveolens have not, to our knowledge, been previously reported. However, it has been found that limonene, the main component of B. graveolens leaf oil, has exhibited in-vitro anti proliferative action on BW 5147 murine lymphoma cells [15] , but was inactive on MCF-7 human adenocarcinoma cells [16] . Limonene has shown also antiparasitic activity against Leishmania amazonensis both in vitro and in vivo [17] . The mechanism of action ascribed to limonene have been associated with the apoptosis induction and increase of NO levels in the cell culture [18] , which could explain the activity shown against Leishmania. Notably, the other major components in B. graveolens leaf oil, β-elemene and β-ocimene, have also shown cytotoxic activity. β-Elemene has demonstrated cytotoxic activity against murine P388 lymphocytic leukemia [19] , human A2780 ovarian carcinoma [20] , and human HEp-2 laryngeal carcinoma cells, while β-ocimene has shown cytotoxic activity against human MDA-MB-231 and Hs 578T breast carcinoma cell lines [21] . The activity of B. graveolens oil is a complex mixture (Table 1 ) and the combination of components may be acting synergistically or antagonistically [16] , and therefore the activities of the oil are not likely due to only the major components.
In-vitro studies have shown amphotericin B (IC 50 = 0.14 μg/mL) to be more active against Leishmania mexicana promastigotes than B. graveolens oil, but Bursera oil has comparable IC 50 values to commonly used antileishmanial drugs such as pentostam (IC 50 = 10,000 μg/mL) and aminosidine (IC 50 = 54 μg/mL) [22] . In addition, B. graveolens oil was more active (IC 50 < 50 μg/mL) than other essential oils studied recently, such as Ocimum gratissimum (IC 50 = 75 μg/mL) and Lippia sidoides (IC 50 = 89 μg/mL) against Leishmania spp. [23] .
Against MCF-7 breast tumor cells, the oil showed lower activity in comparison with conventional drugs, such as tamoxifen (IC 50 = 19.7 μg/mL) [24] or doxorubicin (IC 50 = 6.6 μg/mL) [25] . However, Chemical and anti-proliferative properties of Bursera graveolens Natural Product Communications Vol. 7 (11) 2012 1533 other essential oils studied including Satureja thymbra, Sideritis perfoliata, Laurus nobilis, Pistacia palestina and Salvia officinalis did not showed appreciable activities against this cell line at concentrations as high as 400 µg/mL [26] . Other essential oils like Schinus molle and Schinus terebinthifolius [27] , however, have shown comparable cytotoxic activities on MCF-7 cells (IC 50 = 47 and 54 μg/mL, respectively) to Bursera oil.
In conclusion, this study demonstrates the utility of essential oils as promissory alternative antiproliferative products. Further evaluation of essential oil from B. graveolens against experimental models in animals are in progress in our laboratories.
Experimental
Plant Material: B. graveolens was collected in Lisa, La Habana, Cuba, during September 2010. A voucher specimen (No. 42675) was deposited in the National Ecology and Systematic Institute, Havana, Cuba. The essential oil was obtained by hydrodistillation of the aerial parts of the plant, using Clevenger type equipment.
Gas Chromatographic -Mass Spectral Analysis:
The B. graveolens essential oil was analyzed by GC-MS using an Agilent 6890 GC with Agilent 5973 mass selective detector [MSD, operated in the EI mode (electron energy = 70 eV), scan range = 45-400 amu, and scan rate = 3.99 scans/sec], and an Agilent ChemStation data system. The GC column was an HP-5ms fused silica capillary with a (5% phenyl)-polymethylsiloxane stationary phase, film thickness of 0.25 μm, a length of 30 m, and an internal diameter of 0.25 mm. The carrier gas was helium with a column head pressure of 48.7 kPa and a flow rate of 1.0 mL/min. Inlet temperature was 200°C and interface temperature was 280°C. The GC oven temperature program was used as follows: 40°C initial temperature, hold for 10 min; increased at 3°C/min to 200°C; increased 2°/min to 220°C. A 1 % w/v solution of the sample in dichloromethane was prepared and 1 μL was injected using a splitless injection technique. Identification of the oil components was based on their retention indices determined by reference to a homologous series of nalkanes, and by comparison of their mass spectral fragmentation patterns with those reported in the literature [28] and stored on the MS library [NIST database (G1036A, revision D.01.00)/ChemStation data system (G1701CA, version C.00.01.080]. The percentages of each component are reported as raw percentages based on total ion current without standardization.
Cell and Parasite Cultures:
Human MCF-7 adenocarcinoma cells (ATCC No. HTB-22) were grown in 25 cm 2 tissue culture flasks with feeding medium consisting RPMI 1640 medium with Lglutamine and 7.5% NaHCO 3 , 100,000 units of penicillin and 10.0 mg streptomycin per liter, 15 mM Hepes at a pH of 7.35, and supplemented with 10% fetal bovine serum at 37°C in a 5% CO 2 incubator. Medium was replaced every two days to ensure optimum growth conditions. L. amazonensis (MHOM/77BR/LTB0016) was kindly provided by the Department of Immunology, Oswaldo Cruz Foundation (FIOCRUZ), Brazil. Parasites were routinely isolated from mouse lesions and maintained as promastigotes at 26ºC in Schneider's medium (SIGMA, St. Louis, MO, USA) containing 10% heatinactivated fetal bovine serum (HFBS) (SIGMA, St. Louis, MO, USA), 100 g of streptomycin/mL, and 100 U of penicillin/mL. The parasites were used after three in-vitro passages.
Anti-Tumoral Cell Assay:
In-vitro cytotoxic activity of the essential oil on MCF-7 cells was carried out using the MTT assay [29] . Cells were plated in 96-well cell culture plates at a concentration of 1.0  10 5 cells per well for a final volume of 100 µL. Plates were allowed to incubate for 48 hours in a 5% CO 2 environment at 37˚C. After 48 hours, the medium was removed by suction from each well, and 100 µL of fresh medium containing 1.0 μL or 0.5 μL of DMSO solution of the essential oil (1% w/w in DMSO) to give final concentrations of 100 µg/mL and 50 μg/mL, respectively, of essential oil. All tests were done in quadruplicate. Medium and DMSO control wells were also included as negative controls; tingenone [30] was used as a positive control. After 48 hours, the medium and compound mixture was removed by suction and 100 µL of a 0.83 mg/mL MTT solution in medium (2 mL of 0.05 g MTT in 10 mL of 10 mM phosphate buffered saline, pH 7.36, and 10 mL of medium) was added to each well and allowed to incubate for 4 hours. After 4 hours, the MTT mixture and medium were removed by suction, and 100 µL of DMSO was added to each well to dissolve the formazan crystals. The plates were then incubated for 15 minutes at 37ºC and the absorbance in each well was determined with a microplate reader (Molecular Devices SpectraMax Plus384) at 570 nm. Average absorbances, standard deviations, and percent kill ratios (%kill cmpd /%kill DMSO ) were calculated. Median inhibitory concentration (IC 50 ) values were determined using the Reed-Muench method [31] .
Anti-Amastigote Activity: Macrophages were harvested from peritoneal cavities of normal BALB/c mice in RPMI medium (Sigma). A volume of 1 mL of cells were plated at 10 6 /mL in and incubated at 37C under an atmosphere of 5% CO 2 for 2 h. Nonadherent cells were removed and stationary-phase L. amazonensis promastigotes were added at a 4:1 parasite/macrophage ratio. The cultures were incubated for 4 h, washed to remove free parasites and 10 µL of different essential oil concentrations were added between 6.25 and 50 µg/mL, two times, for 48 h. Control cultures were included, which were treated with 10 µL of distilled water. The cultures were then fixed with absolute methanol, stained with Giemsa, and examined under light microscopy [32] . The number of intracellular amastigotes and the percentage of infected macrophages were determined. The infection rates were obtained by multiplying the percentage of infected macrophages by the number of amastigotes per infected macrophage. The results were expressed as percent of reduction of the infection rate (%IR) in comparison to that of the controls [33] .
Macrophage Cytotoxicity Assay:
Resident macrophages were collected from peritoneal cavities of normal BALB/c mice in ice-cold RPMI 1640 medium (SIGMA, St. Louis, Mo, USA), supplemented with antibiotics, seeded at 30,000 cells/well and allowed to adhere for 2 h at 37C in 5% CO 2 . After non-adherent cells were removed by washing with PBS, dilutions of the essential oil, in 1 μL of DMSO, were added in 200 μL of medium with 10% HFBS and antibiotics. The macrophages were treated with six concentrations of the product and cultures treated with 1 μL of DMSO were included as controls. The cytotoxicity was determined after 3 days of incubation using the colorimetric assay with 3-[4,5dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) (SIGMA, St. Louis, MO, USA). MTT solutions were prepared at 5 mg/mL in PBS, filtered and sterilized at the time of use and 15 μL of each solution were added to each well. After incubation for an additional 4 h, the formazan crystals were dissolved by addition of 100 μL of DMSO. The optical density was determined using an EMS Reader MF Version 2.4-0 at a test wavelength of 560 nm and a reference wavelength of 630 nm [34] . The 50% cytotoxic concentration (CC 50 ) was obtained from dose-response curves fit to data by means of the equation for the sigmoidal Emax model. Selectivity indices (SI) were then calculated by dividing the CC 50 for peritoneal macrophages of BALB/c mice by the IC 50 for Leishmania amastigotes [35] .
